Form 8-K - Current report:
SEC Accession No. 0001193125-19-272080
Filing Date
2019-10-23
Accepted
2019-10-23 07:30:39
Documents
6
Period of Report
2019-10-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d821648d8k.htm 8-K 26776
2 EX-10.1 d821648dex101.htm EX-10.1 6745
3 EX-10.2 d821648dex102.htm EX-10.2 32426
4 EX-99.1 d821648dex991.htm EX-99.1 10422
5 GRAPHIC g821648g1022203850773.jpg GRAPHIC 3284
6 GRAPHIC g821648g19c01.jpg GRAPHIC 3760
  Complete submission text file 0001193125-19-272080.txt   87607
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

EIN.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 191162657
SIC: 2834 Pharmaceutical Preparations